3 Diabetes Biotechs That Could Surge 50% or More in 2018 Post author:Sam Post published:January 21, 2018 Post category:BioPharma Wall Street projects these three biotechs will grow the fastest over the next 12 months. Source: BioSpace You Might Also Like Paragon Bioservices to Create 200 New Jobs in Expansion January 22, 2018 Endologix Announces Positive Clinical Results From The LEOPARD Clinical Study August 16, 2017 How Much Cash Kite Pharma's Execs Made From Its $12 Billion Gilead Deal September 28, 2017
